NextCure, Inc. Contracts & Agreements
40 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (4)
- Human Resources (16)
- Intellectual Property (2)
- Real Estate (4)
- Uncategorized (2)
- Research Collaboration and Co-Development Agreement, dated as of November 9, 2022, by and between Nextcure, Inc. and LegoChem Biosciences, Inc (Filed With SEC on March 21, 2024)
- Sixth Amendment to Lease Agreement, dated April 19, 2023, by and between the Company and ARE-8000/9000-10000 Virginia Manor, LLC (Filed With SEC on May 4, 2023)
- Employment Agreement, effective as of February 28, 2023, by and between the Company and Kevin G. Shaw (Exhibits and schedules have been omitted pursuant to Item 601 of Regulation... (Filed With SEC on March 2, 2023)
- Fifth Amendment to Lease Agreement, dated November 28, 2022, by and between the Company and ARE-8000/9000/10000 Virginia Manor, LLC. (Exhibits and schedules have been omitted... (Filed With SEC on March 2, 2023)
- Third Amendment to License Agreement and SRA, dated as of September 14, 2022, by and between the Company and Yale University. (Exhibits and schedules have been omitted pursuant to... (Filed With SEC on March 2, 2023)
- Fourth Amendment to Lease Agreement, dated June 10, 2022, by and between the Company and ARE-8000/9000/10000 Virginia Manor, LLC. (Exhibits and schedules have been omitted... (Filed With SEC on March 2, 2023)
- Employment Agreement, effective as of January 11, 2021, by and between the Company and Han Myint, M.D. (**Exhibits and schedules have been omitted pursuant to Item 601 of... (Filed With SEC on March 3, 2022)
- Second Amendment to License Agreement and SRA, dated as of October 20, 2021, by and between the Company and Yale University. (**Exhibits and schedules have been omitted pursuant... (Filed With SEC on March 3, 2022)
- Second Amendment to Lease Agreement, dated February 19, 2020, by and between the Company and ARE-8000/9000/10000 Virginia Manor, LLC. (**Exhibits and schedules have been omitted... (Filed With SEC on March 3, 2022)
- Third Amendment to Lease Agreement, dated February 4, 2022, by and between the Company and ARE-8000/9000/10000 Virginia Manor, LLC. (**Exhibits and schedules have been omitted... (Filed With SEC on March 3, 2022)
- First Amendment to the NextCure, Inc. 2015 Omnibus Incentive Plan dated September 30, 2021 (Filed With SEC on November 4, 2021)
- Sales Agreement, dated May 6, 2021, between the Company and SVB Leerink LLC (Filed With SEC on May 6, 2021)
- Amendment to License Agreement and SRA, dated as of April 25, 2020, by and between the Company and Yale University (Filed With SEC on March 4, 2021)
- Non-Employee Director Compensation Program (Filed With SEC on September 14, 2020)
- Consulting Agreement, effective as of August 4, 2020, by and between the Company and Kevin Heller, M.D (Filed With SEC on August 6, 2020)
- Employment Agreement, effective July 27, 2020, between NextCure, Inc. and Solomon Langermann, Ph.D (Filed With SEC on July 31, 2020)
- Employment Agreement, effective July 27, 2020, between NextCure, Inc. and Steven P. Cobourn (Filed With SEC on July 31, 2020)
- Employment Agreement, effective July 27, 2020, between NextCure, Inc. and Michael Richman (Filed With SEC on July 31, 2020)
- Description of Registered Securities (Filed With SEC on March 12, 2020)
- Form of Underwriting Agreement (Filed With SEC on November 12, 2019)
- First Amendment to Lease Agreement, dated August 2, 2019, by and between the Company and ARE-8000/9000/10000 Virginia Manor, LLC (Filed With SEC on November 12, 2019)
- Form of Underwriting Agreement (Filed With SEC on April 29, 2019)
- NextCure, Inc. 2019 Omnibus Incentive Plan (Filed With SEC on April 29, 2019)
- Forms of Stock Option Agreement under the NextCure, Inc. 2019 Omnibus Incentive Plan (Filed With SEC on April 29, 2019)
- Form of Restricted Stock Agreement under the NextCure, Inc. 2019 Omnibus Incentive Plan (Filed With SEC on April 29, 2019)
- Form of Restricted Stock Unit Agreement under the NextCure, Inc. 2019 Omnibus Incentive Plan (Filed With SEC on April 29, 2019)
- NextCure, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on April 29, 2019)
- Non-Employee Director Compensation Program (Filed With SEC on April 29, 2019)
- NextCure, Inc. 2015 Omnibus Incentive Plan, as amended (Filed With SEC on April 12, 2019)
- Form of Indemnification Agreement by and between the Company and each of its directors and executive officers (Filed With SEC on April 12, 2019)
- Research and Development Collaboration Agreement, dated as of November 2, 2018, by and between the Company and Eli Lilly and Company (Filed With SEC on April 12, 2019)
- Corporate Sponsored Research Agreement, dated as of December 29, 2015, by and between the Company and Yale University (Filed With SEC on April 12, 2019)
- License Agreement, dated as of December 29, 2015, by and between the Company and Yale University (Filed With SEC on April 12, 2019)
- Amended and Restated Investors' Rights Agreement, dated as of November 5, 2018, by and among the Company and the investors party thereto (Filed With SEC on April 12, 2019)
- Form of Stock Option Agreement under the NextCure, Inc. 2015 Omnibus Incentive Plan (Filed With SEC on April 12, 2019)
- Lease Agreement, dated as of January 30, 2019, by and between the Company and ARE-8000/9000/10000 Virginia Manor, LLC (Filed With SEC on April 12, 2019)
- Employment Letter, dated as of September 12, 2016, by and between the Company and Michael Richman (Filed With SEC on April 12, 2019)
- Employment Letter, dated as of December 18, 2017, by and between the Company and Steven P. Cobourn (Filed With SEC on April 12, 2019)
- Employment Letter, dated as of September 12, 2016, by and between the Company and Sol Langermann, Ph.D (Filed With SEC on April 12, 2019)
- Amended and Restated Sublease Agreement, dated as of March 15, 2019, by and between the Company and Lupin, Inc (Filed With SEC on April 12, 2019)